Skip to main content
OpenTrials
Recruiting

NCT Number: NCT01821456

Cologne Cohort of Neutropenic Patients (CoCoNut)

The Cologne Cohort of Neutropenic Patients (CoCoNut) is a non-interventional cohort study assessing risk factors, interventions, and outcome of immunosuppressed patients with or without opportunistic infections.

Recruiting

Interested in participating?

Request Info

Key information

Age range

1 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

About this study

This prospective cohort was established with the aim of a comprehensive data collection of all patients developing neutropenia after receiving chemotherapy for any kind of malignant disease, treated in the University Hospital of Cologne.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • immunosuppressed patients

Exclusion criteria

  • none

Treatment and study plan

Antiinfectives

Drug

To analyze to efficacy of (novel) drug therapies

Other names: Antifungals, Antibacterials, Antivirals

Primary outcomes

  1. Long-term survival of hematology and oncology patients following neutropenia

    Time frame: 2 years following last follow-up

Sponsors and collaborators

Lead sponsor

University Hospital of Cologne

Other

Registry information

Official study title

The Cologne Cohort of Neutropenic Patients (CoCoNut) - a Non-interventional Cohort Study Assessing Risk Factors, Interventions, and Outcome of Immunosuppressed Patients With or Without Opportunistic Infections

Acronym: CoCoNut

Important dates

Study start
1995
Primary completion
2050
Study completion
2050
First posted
Apr 1, 2013
Registry last updated
Apr 1, 2013

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.